GlycoMimetics Inc Clinical Data Update from the Abstracts for the Upcoming ASCO Conference Call

18/5/2017 8:30

Conference Call GlycoMimetics Inc

GlycoMimetics Inc Conference call will be held on May 18, 2017. During the earnings conference call's session GlycoMimetics Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact GlycoMimetics Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
We are a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using our expertise in carbohydrate chemistry and knowledge of carbohydrate biology, we are developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. We believe this represents an innovative approach to drug discovery to treat a wide range of diseases. We are focusing our initial efforts on drug candidates for rare diseases that we believe will qualify for orphan drug designation.    
Read more Conference Call

GlycoMimetics Inc (GLYC)

9708 Medical Center Drive, Rockville Maryland 20850, United States